The Role of Exosomes in The Pathogenesis of Parkinson's Disease and Potential Therapeutic Strategies
DOI:
https://doi.org/10.54097/78mhby86Keywords:
Exosomes, Pathogenesis of Parkinson's Disease, Potential Therapeutic StrategiesAbstract
The pathogenesis of Parkinson's disease (PD), the second most prevalent neurodegenerative disorder after Alzheimer's disease, continues to be a focal point of research within the medical community. In recent years, advancements in exosome research have revealed a significant role of exosomes in the pathogenesis of Parkinson's disease. Exosomes, distinguished by their lipid bilayer membrane, are small vesicles actively secreted by cells. Exosomes play a crucial role not only in modulating the immune response and serving as transporters in inflammatory pathways but also have a substantial impact on tumor initiation, progression, and therapeutic strategies in the field of medicine. In PD, disturbances in exosome functionality can directly influence neuronal health. Research suggests that exosomes in PD patients may experience changes in quantity, composition, and function. These alterations have the potential to cause neuronal damage and death, thus exacerbating the disease progression. This study delves into the role of exosomes in the pathogenesis of PD and explores potential therapeutic approaches.
Downloads
References
T. B. Stoker and R. A. Barker. Recent developments in the treatment of Parkinson's Disease[J]. F1000Res, 2020, 9.
E. Tolosa, et al. Challenges in the diagnosis of Parkinson's disease[J]. Lancet Neurol, 2021, 20(5): 385-397.
L. V. Kalia and A. E. Lang. Parkinson's disease[J]. Lancet, 2015, 386(9996): 896-912.
T. Li and W. Le. Biomarkers for Parkinson's Disease: How Good Are They?[J]. Neurosci Bull, 2020, 36(2): 183-194.
L. Yuan and J. Y. Li. Exosomes in Parkinson's Disease: Current Perspectives and Future Challenges[J]. ACS Chem Neurosci, 2019, 10(2): 964-972.
D. M. Pegtel and S. J. Gould. Exosomes[J]. Annu Rev Biochem, 2019, 88: 487-514.
Y. Fang, et al. Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges [J]. Autoimmun Rev, 2023, 22(3): 103260.
J. Lee, et al. Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis[J]. Clin Chim Acta, 2016, 462: 118-126.
R. Mirzaei, et al. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases[J]. J Neuroimmunol, 2021, 358: 577640.
A. F. Hill. Extracellular Vesicles and Neurodegenerative Diseases[J]. J Neurosci, 2019, 39(47): 9269-9273.
D. K. Simon, et al. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology[J]. Clin Geriatr Med, 2020, 36(1): 1-12.
E. R. Dorsey and B. R. Bloem. The Parkinson Pandemic-A Call to Action[J]. JAMA Neurol, 2018, 75(1): 9-10.
C. M. Lill and C. Klein. [Epidemiology and causes of Parkinson's disease] [J]. Nervenarzt, 2017, 88(4): 345-355.
Y. Zhao, et al. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease][J]. Se Pu, 2023, 41(12): 1073-1083.
H. Wei, et al. Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis[J]. Cell Death Dis, 2020, 11(4): 290.
M. J. Haney, et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy[J]. J Control Release, 2015, 207: 18-30.
M. Parmar, et al. The future of stem cell therapies for Parkinson disease[J]. Nat Rev Neurosci, 2020, 21(2): 103-115.
B. R. Bloem, et al. Parkinson's disease[J]. Lancet, 2021, 397(10291): 2284-2303.
W. Jiang, et al. Dairy foods intake and risk of Parkinson's disease: a dose-response meta-analysis of prospective cohort studies[J]. Eur J Epidemiol, 2014, 29(9): 613-9.
D. Kaya. Optimization of SVM Parameters with Hybrid CS-PSO Algorithms for Parkinson's Disease in LabVIEW Environment[J]. Parkinsons Dis, 2019, 2019: 2513053.
C. López-Otín, et al. Hallmarks of aging: An expanding universe[J]. Cell, 2023, 186(2): 243-278.
S. Isik, et al. Microglia Mediated Neuroinflammation in Parkinson's Disease[J]. Cells, 2023, 12(7).
K. L. Li, et al. Role of exosomes in the pathogenesis of inflammation in Parkinson's disease[J]. Neural Regen Res, 2022, 17(9): 1898-1906.
M. D. A. Paskeh, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling[J]. J Hematol Oncol, 2022, 15(1): 83.
D. A. Chistiakov and A. A. Chistiakov. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters[J]. Acta Neurol Belg, 2017, 117(1): 43-51.
R. Kalluri and V. S. LeBleu. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478).
A. Vahabi, et al. Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities[J]. Biochem Pharmacol, 2022, 200: 115038.
F. Properzi, et al. Exosomes: the future of biomarkers in medicine[J]. Biomark Med, 2013, 7(5): 769-78.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
